Submit Buy Request
View Synopsis & Table of contentDiscover the booming Enzalutamide soft capsules market! Our analysis reveals a $1.5 billion market in 2025, projected to grow at 8% CAGR through 2033. Learn about key drivers, trends, restraints, and leading companies like Astellas Pharma and Pfizer shaping this dynamic landscape.
Total Amount: $0
$6960.00
$5220.00
$3480.00
Our Clients
Choose Payment Method
Setting up secure checkout...
Secure Encrypted Transaction
Or
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.
Key Highlights of Report
Jan, 2026
115
Tables
Base Year: 2025.
Coverage: 18 Countries
Companies: 15+
Connect With us
